Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7211-7216

  Wang, Ziqiu ^a   Wang, Meifang ^a   Kar, Siddhartha ^a   Carr, Brian I ^a   Southwick, Eileen C ^a   Lazo, John S ^a   Rosi, Kathryn S ^a   Wilcox, Craig S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; THIOL DERIVATIVE; VITAMIN K GROUP;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME INACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ACETYLCYSTEINE; CARCINOMA, HEPATOCELLULAR; CATALASE; CDC25 PHOSPHATASE; CELL DIVISION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DRUG INTERACTIONS; ENZYME ACTIVATION; GLUTATHIONE; GROWTH INHIBITORS; HUMANS; LIVER NEOPLASMS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; SULFHYDRYL COMPOUNDS; VITAMIN K;

EID: 0035477463     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cell cycle checkpoints: Preventing an identity crisis
2. How proteolysis drives the cell cycle
3. Viewpoint: Putting the cell cycle in order
4. Cancer cell cycle
5. 1-S phase protein kinase
6. 1 in mammalian fibroblast
7. cdc2 activation: Identification of an activating kinase
8. Principles of CDK regulation
9. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15
10. CIP1 and cdc25A: Competition between an inhibitor and an activator of cyclin-dependent kinases
11. cdc2 kinase in fission yeast
12. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: Evidence for multiple roles of mitotic cyclins
13. Cdc25A is a novel phosphatase functioning early in the cell cycle
14. Cdc25A cell-cycle phosphatase as a target of c-myc
15. Human Cdc25A inactivation in response to S phase inhibition and its role in preventing premature mitosis
16. Vitamin K in the treatment of cancer
17. Biochemical mechanism of oxidation damage by redox-cycling drugs
18. Molecular basis of vitamin K-dependent γ-carboxylation
19. The growth inhibitory effects of vitamin K and their actions on gene expression
20. Growth inhibition of hepatoma cells induced by vitamin K and its analogs
21. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation
22. Involvement of hepatocyte epidermal growth factor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin
23. Inhibition of hepatoma cell growth in vitro by arylating and non-arylating K vitamin analogs
24. 3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase
25. Targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation
26. Cdc25A inhibition and cell cycle arrest by a synthetic thioalkyl vitamin K analogue
27. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water
28. Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor Cdc25 dual-specificity phosphatases
29. 3 oxide inhibit growth of Hep3B and HepG2 cells
30. Protein-tyrosine phosphatases
31. Structure and function of the protein tyrosine phosphatases
32. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
33. 1 arrest induced by ultraviolet irradiation
34. 1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
35. The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which downmodulates p21WAF/CIP/SDII in S phase
36. CIP1
37. WAF1 gene activities
38. 1 arrest and apoptosis
39. Cyclin dependent kinase inhibitors